Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew

1 Issue per year


IMPACT FACTOR 2016 (Open Medicine): 0.294
IMPACT FACTOR 2016 (Central European Journal of Medicine): 0.116

CiteScore 2016: 0.28

SCImago Journal Rank (SJR) 2015: 0.140
Source Normalized Impact per Paper (SNIP) 2015: 0.154

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 3, Issue 1 (Mar 2008)

Issues

Coffee consumption and type 2 diabetes — An extensive review

Siamak Bidel
  • Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute, Helsinki, Finland
  • Department of Public Health, University of Helsinki, Helsinki, Finland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Gang Hu
  • Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute, Helsinki, Finland
  • Department of Public Health, University of Helsinki, Helsinki, Finland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jaakko Tuomilehto
  • Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute, Helsinki, Finland
  • Department of Public Health, University of Helsinki, Helsinki, Finland
  • South Ostrobothnia Central Hospital, Seinäjoki, Finland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2008-03-01 | DOI: https://doi.org/10.2478/s11536-007-0059-6

Abstract

Coffee is a complex mixture of potentially active chemicals. It contains significant amounts of phenolic polymers, chlorogenic acid and also caffeine. Agricultural factors, roasting, blending, and brewing determine coffee’s chemical composition. Recent epidemiological studies suggest that habitual coffee consumption may help to prevent some chronic diseases including type 2 diabetes. Despite reports from the clinical trials of the effect of caffeine on decreasing insulin sensitivity, long-term prospective studies revealed that coffee may improve fasting glucose, glucose tolerance and insulin sensitivity as well. In the most recent publication habitual coffee drinkers have a lower total and cardiovascular mortality rate among diabetic subjects.

Keywords: Coffee; Type 2 diabetes; Glucose tolerance

  • [1] Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 2004, 27, 1047–1053 http://dx.doi.org/10.2337/diacare.27.5.1047CrossrefGoogle Scholar

  • [2] Amos A.F., McCarty D.J. and Zimmet P., The rising global burden of diabetes and its complications: Estimates and projections to the year 2010, Diabet. Med., 1997, 14, S7–S85 http://dx.doi.org/10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-ICrossrefGoogle Scholar

  • [3] Bennett P.H., Type 2 diabetes among the Pima Indians of Arizona: an epidemic attributable to environmental change, Nutrition Reviews, 1999, 57, S51–54 http://dx.doi.org/10.1111/j.1753-4887.1999.tb01788.xCrossrefGoogle Scholar

  • [4] Lako J.V., Nguyen V.C., Dietary patterns and risk factors of diabetes mellitus among urban indigenous women in Fiji, Asia Pacific J. of Clin. Nutr., 2001, 10, 188–193 http://dx.doi.org/10.1046/j.1440-6047.2001.00255.xCrossrefGoogle Scholar

  • [5] Hetzel B., Michael T., The lifestyle factor: Lifestyle and health, Melbourne Pinguin, 1987. Google Scholar

  • [6] Tuomilehto J., Tuomilehto-Wolf E., Zimmet P., Alberti K.G.M.M., Knowler W.C., Primary prevention of diabetes mellitus, In: Alberti K.G.M.M., Zimmet P., DeFronzo R.A., Keen H. (Eds.) International Textbook of Diabetes Mellitus, 2nd ed., Wiley, Chichester New York Brisban Toronto, 1997 Google Scholar

  • [7] Clifford M.N., Chlorogenic acid and other cinnamates-nature, occurrence and dietary burden, J. Sci. Food Agric., 1999, 79, 362–372 http://dx.doi.org/10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-DCrossrefGoogle Scholar

  • [8] Clifford M.N., Chlorogenic acid and other cinnamates-nature, occurrence, dietary burden, absorption and metabolism, J. Sci. Food Agric., 2000, 80, 1033–1043 http://dx.doi.org/10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-TCrossrefGoogle Scholar

  • [9] Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W., Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus, J. Clin. Invest., 1993 91, 301–307 Google Scholar

  • [10] Meier J.J., Hucking K., Holst J.J., Deacon C.F., Schmiegel W.H., Nauck M.A., Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes”, Diabetes, 2001, 50, 2497–2504 http://dx.doi.org/10.2337/diabetes.50.11.2497CrossrefGoogle Scholar

  • [11] Tuomilehto J., Tuomilehto-Wolf E., Virtala E., LaPorte R., Coffee consumption as trigger for insulin dependent diabetes mellitus in childhood, B.M.J., 1990, 300, 642–643 Google Scholar

  • [12] Barbagallo M., Dominguez L.J., Galioto A., Ferlisi A., Cani C., Malfa L., et al., Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X, Mol. Aspects Med., 2003, 24, 39–52 http://dx.doi.org/10.1016/S0098-2997(02)00090-0CrossrefGoogle Scholar

  • [13] Paolisso G., Scheen A., D’Onofrio F., Lefebvre P., Magnesium and glucose homeostasis, Diabetologia, 1990, 33, 511–514 http://dx.doi.org/10.1007/BF00404136CrossrefGoogle Scholar

  • [14] Paolisso G., Ravussin E., Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians, J. Clin. Endocrinol. Metab., 1995, 80, 1382–1385 http://dx.doi.org/10.1210/jc.80.4.1382CrossrefGoogle Scholar

  • [15] Paolisso G., Barbagallo M., Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium, Am. J. Hypertens., 1997, 10, 346–355 http://dx.doi.org/10.1016/S0895-7061(96)00342-1CrossrefGoogle Scholar

  • [16] Matsui T., Ueda T., Oki T., Sugita K., Terahara N., Matsumoto K., alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 2. Alpha-Glucosidase inhibition by isolated acylated anthocyanins, J. Agric. Food. Chem., 2001, 49, 1952–1956 http://dx.doi.org/10.1021/jf0012502CrossrefGoogle Scholar

  • [17] Kobayashi Y., Suzuki M., Satsu H., Arai S., Hara Y., Suzuki K., et al., Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism, J. Agric. Food. Chem., 2000, 48, 5618–5623 http://dx.doi.org/10.1021/jf0006832CrossrefGoogle Scholar

  • [18] Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W., Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus, J. Clin. Invest., 1993, 91, 301–307 CrossrefGoogle Scholar

  • [19] Meier J.J., Hucking K., Holst J.J., Deacon C.F., Schmiegel W.H., Nauck M.A., Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes, Diabetes, 2001, 50, 2497–2504 http://dx.doi.org/10.2337/diabetes.50.11.2497CrossrefGoogle Scholar

  • [20] Newgard C.B., Foster D.W., McGarry J.D., Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding, Diabetes, 1984, 33, 192–195 http://dx.doi.org/10.2337/diabetes.33.2.192CrossrefGoogle Scholar

  • [21] Youn J.H., Youn M.S., Bergman R.N., Synergism of glucose and fructose in net glycogen synthesis in perfused rat livers, J. Biol. Chem., 1986, 261, 15960–15969 Google Scholar

  • [22] Arion W.J., Canfield W.K., Ramos F.C., Schindler P.W., Burger H.J., Hemmerle H., et al., Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase, Arch. Biochem. Biophys., 1997, 339, 315–322 http://dx.doi.org/10.1006/abbi.1996.9874CrossrefGoogle Scholar

  • [23] Andrade-Cetto A., Wiedenfeld H., Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats, J. Ethnopharmacol., 2001, 78, 145–149 http://dx.doi.org/10.1016/S0378-8741(01)00335-XCrossrefGoogle Scholar

  • [24] Keijzers G.B., De Galan B.E., Tack C.J., Smits P., Caffeine can decrease insulin sensitivity in humans, Diabetes Care, 2002, 25, 364–369 http://dx.doi.org/10.2337/diacare.25.2.364CrossrefGoogle Scholar

  • [25] Denaro C.P., Brown C.R., Jacob P., Benowitz N.L., Effects of caffeine with repeated dosing, Eur. J. Clin. Pharmacol., 1991, 40, 273–278 http://dx.doi.org/10.1007/BF00315208CrossrefGoogle Scholar

  • [26] Arnlov J., Vessby B., Riserus U., Coffee consumption and insulin sensitivity, JAMA, 2004, 291, 1199–1201. http://dx.doi.org/10.1001/jama.291.10.1199-bCrossrefGoogle Scholar

  • [27] Yeni-Komshian H., Carantoni M., Abbasi F., Reaven G.M., Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers, Diabetes Care, 2002, 23, 171–175 http://dx.doi.org/10.2337/diacare.23.2.171CrossrefGoogle Scholar

  • [28] Laakso M., How good is insulin level for insulin resistance?, Am. J. Epidemiol., 1992, 137, 959–965 Google Scholar

  • [29] Ferrannini E. Mari A., How to measure insulin sensitivity, J. Hypertens., 1998, 16, 895–906 http://dx.doi.org/10.1097/00004872-199816070-00001CrossrefGoogle Scholar

  • [30] Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Moralles P.A. Stern M.P., Prospective analaysis of the insulin-resistance syndrome (syndrome X), Diabetes, 1992, 41, 715–722 http://dx.doi.org/10.2337/diabetes.41.6.715CrossrefGoogle Scholar

  • [31] Zavaroni I., Bonora E., Pagliara M., Dall’Aglio E., Luchetti L., Buonanno G., et al., Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance, N. Eng. J. Med., 1989, 320, 702–706 http://dx.doi.org/10.1056/NEJM198903163201105CrossrefGoogle Scholar

  • [32] Despres J.P., Lamarch B., Maurige P., Cantin B., Dagenais G.R., Moorjani S., et al., Hyperinsulinemia as an independent risk factor for ischemic heart disease, N. Eng. J. Med., 1996, 334, 952–957 http://dx.doi.org/10.1056/NEJM199604113341504CrossrefGoogle Scholar

  • [33] Fontbonne A., Charles M.A., Thibult N., Richard J.L., Claude J.R., Warnet J.M., et al., Hyperinsulinemia as a predictor of coronary heart disease mortality in healthy population: the Paris Prospective Study, 15-year follow-up, Diabetologia, 1991, 34, 356–361 http://dx.doi.org/10.1007/BF00405009CrossrefGoogle Scholar

  • [34] Panagiotakos D.B., Pitsavos C., Zampelas A., Zeimbekis A., Chrysohoou C., Papademetriou L., et al., The association between coffee consumption and plasma total homocysteine levels: the “ATTICA” study, Heart. Vessels., 2004, 19, 280–286 http://dx.doi.org/10.1007/s00380-004-0779-3CrossrefGoogle Scholar

  • [35] Panagiotakos D.B., Pitsavos C,. Zeimbekis A., Chrysohoou C., Stefanadis C., The association between lifestyle-related factors and plasma homocysteine levels in healthy individuals from the “ATTICA” Study, Int. J. Cardiol., 2005, 98, 471–477 http://dx.doi.org/10.1016/j.ijcard.2003.12.036CrossrefGoogle Scholar

  • [36] Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., Selhub J., Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort, Am. J. Clin. Nutr., 2001, 73, 613–621 Google Scholar

  • [37] Martos R., Valle M., Morales R., Canete R., Gavilan M.I., Sanchez-Margalet V., Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children, Metabolism., 2006, 55, 72–77 http://dx.doi.org/10.1016/j.metabol.2005.07.008CrossrefGoogle Scholar

  • [38] Cho N.H., Lim S., Jang H.C., Park H.K., Metzger B.E., Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study, Diabetes Care., 2005, 28, 2750–2755 http://dx.doi.org/10.2337/diacare.28.11.2750CrossrefGoogle Scholar

  • [39] Peyrin-Biroulet L., Gueant J.L., Roblin X., Coffee and diabetes: is homocysteine the missing link?, Arch. Intern. Med., 2007, 167, 204 http://dx.doi.org/10.1001/archinte.167.2.204-aCrossrefGoogle Scholar

  • [40] Mascitelli L., Pezzetta F., Sullivan J.L., Inhibition of iron absorption by coffee and the reduced risk of type 2 diabetes mellitus, Arch. Intern. Med., 2007, 167, 204–205 http://dx.doi.org/10.1001/archinte.167.2.204-bCrossrefGoogle Scholar

  • [41] Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., Hu F.B., Body iron stores in relation to risk of type 2 diabetes in apparently healthy women, JAMA., 2004, 291, 711–717 http://dx.doi.org/10.1001/jama.291.6.711CrossrefGoogle Scholar

  • [42] Facchini F.S., Saylor K.L., Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate intolerant patients, Ann. N. Y. Acad. Sci. 2002, 967, 342–351 http://dx.doi.org/10.1111/j.1749-6632.2002.tb04290.xCrossrefGoogle Scholar

  • [43] Petrie H.J., Chown S.E., Belfie L.M., Duncan A.M., McLaren D.H., Conquer J.A., et al., Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss, Am. J. Clin. Nutr., 2004, 80, 22–28 Google Scholar

  • [44] Graham T.E., Sathasivam P., Rowland M., Marko N., Greer F., Battram D., Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test, Can. J. Physiol. Pharmacol., 2001, 79, 559–565 http://dx.doi.org/10.1139/cjpp-79-7-559CrossrefGoogle Scholar

  • [45] Greer F., Hudson R., Ross R., Graham T., Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans, Diabetes, 2001, 50, 2349–2354 http://dx.doi.org/10.2337/diabetes.50.10.2349CrossrefGoogle Scholar

  • [46] Naismith, D.J., Akinyanju, P.A., Szanto, S., Yudkin J., The effect in volunteers of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting, Nutr. Metab., 1970, 12, 144–151 http://dx.doi.org/10.1159/000175287CrossrefGoogle Scholar

  • [47] Van Dam R.M., Pasman W.J., Verhoef P., Effects of coffee consumption on fasting blood glucose and insulin concentrations: randomized controlled trials in healthy volunteers, Diabetes Care, 2004, 27, 2990–2992 http://dx.doi.org/10.2337/diacare.27.12.2990CrossrefGoogle Scholar

  • [48] Battram D.S., Arthur R., Weekes A., Graham T.E., The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men, J. Nutr., 2006, 136, 1276–1280 Google Scholar

  • [49] Yamaji T., Mizoue T., Tabata S., Ogawa S., Yamaguchi K., Shimizu E., et al., Coffee consumption and glucose tolerance status in middle-aged Japanese men, Diabetologia, 2004, 47, 2145–2151 http://dx.doi.org/10.1007/s00125-004-1590-5CrossrefGoogle Scholar

  • [50] Soriguer F., Rojo-Martinez G., de Antonio I.E., Coffee consumption and type 2 diabetes mellitus, Ann. Intern. Med. 2004, 141, 321–323 Google Scholar

  • [51] Agardh E.E., Carlsson S., Ahlbom A., Efendic S., Grill V., Hammar N., et al., Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women, J. Intern. Med., 2004, 255, 645–652 http://dx.doi.org/10.1111/j.1365-2796.2004.01331.xCrossrefGoogle Scholar

  • [52] Van Dam R.M., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., Hoorn study: “Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study, Diabetologia, 2004, 47, 2152–2159 http://dx.doi.org/10.1007/s00125-004-1573-6CrossrefGoogle Scholar

  • [53] Bidel S., Hu G., Sundvall J., Kaprio J., Tuomilehto J., Effects of coffee consumption on glucose tolerance and serum glucose and insulin levels-A cross sectional analysis, Horm. Metab. Res., 2006, 38, 38–43 http://dx.doi.org/10.1055/s-2006-924982CrossrefGoogle Scholar

  • [54] Van Dam R.M., Feskens E.J., Coffee consumption and risk of type 2 diabetes mellitus, Lancet, 2002, 360, 1477–1478 http://dx.doi.org/10.1016/S0140-6736(02)11436-XCrossrefGoogle Scholar

  • [55] Salazar-Martinez E., Willett W.C., Ascherio A., Manson J.E., Leitzmann M.F., Stampfer M.J., et al., Coffee consumption and risk for type 2 diabetes mellitus, Ann. Intern. Med., 2004, 140, 1–8 Google Scholar

  • [56] Carlsson S., Hammar N., Grill V., Kaprio J., Coffee consumption and risk of type 2 diabetes in Finnish twins, Int. J. Epidemiol., 2004, 3, 616–617 http://dx.doi.org/10.1093/ije/dyh185CrossrefGoogle Scholar

  • [57] Rosengren A., Dotevall A., Wilhelmsen L., Thelle D., Johansson S., Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow up study, J. Intern. Med., 2004, 255, 89–95 http://dx.doi.org/10.1046/j.1365-2796.2003.01260.xCrossrefGoogle Scholar

  • [58] Paynter N.P., Yeh H.C., Voutilainen S., Schmidt M.I., Heiss G., Folsom A.R., et al., Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study, Am. J. Epidemiol., 2006, 164, 1075–1084 http://dx.doi.org/10.1093/aje/kwj323CrossrefGoogle Scholar

  • [59] Pereira M.A., Parker E.D., Folsom A.R., Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women, Arch. Intern. Med., 2006, 166, 1311–1316 http://dx.doi.org/10.1001/archinte.166.12.1311CrossrefGoogle Scholar

  • [60] Van Dam R.M., Willett W.C., Manson J.E., Hu F.B., Coffee, Caffeine, and Risk of Type 2 Diabetes: A prospective cohort study in younger and middle-aged U.S. women, Diabetes Care, 2006, 29, 398–403 http://dx.doi.org/10.2337/diacare.29.02.06.dc05-1512CrossrefGoogle Scholar

  • [61] Iso H., Date C., Wakai K., Fukui M., Tamakoshi A., The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults, Ann. Intern. Med., 2006, 144, 554–562 Google Scholar

  • [62] Reunanen A., Heliovaara M., Aho K., Coffee consumption and risk of type 2 diabetes mellitus, Lancet, 2003, 361, 702–703 http://dx.doi.org/10.1016/S0140-6736(03)12583-4CrossrefGoogle Scholar

  • [63] Tuomilehto J., Hu G., Bidel S., Lindstrom J., Jousilahti P., Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women, JAMA, 2004, 291, 1213–1219 http://dx.doi.org/10.1001/jama.291.10.1213CrossrefGoogle Scholar

  • [64] Saremi A., Tulloch-Reid M., Knowler W.C., Coffee consumption and the incidence of type 2 diabetes”, Diabetes Care, 2003, 7, 2211–2212 http://dx.doi.org/10.2337/diacare.26.7.2211CrossrefGoogle Scholar

  • [65] Van Dam R.M., Hu F.B., Coffee consumption and risk of type 2 diabetes: a systematic review, JAMA, 2005, 294, 97–104 http://dx.doi.org/10.1001/jama.294.1.97CrossrefGoogle Scholar

  • [66] Hu G., Jousilahti P., Peltonen M., Bidel S., Tuomilehto J., Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland, Int. J. Obes., 2006, 30, 1742–1749 http://dx.doi.org/10.1038/sj.ijo.0803341CrossrefGoogle Scholar

  • [67] Perry I.J., Wannamethee S.G., Sharper A.G., Prospective study of serum g-glutamyltransferase and risk of NIDDM, Diabetes Care, 1998, 21,732–737 http://dx.doi.org/10.2337/diacare.21.5.732CrossrefGoogle Scholar

  • [68] Nakanishi N., Suzuki K., Tatar K., Serum g-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men, Diabetes Care, 2004, 27, 1427–1432 http://dx.doi.org/10.2337/diacare.27.6.1427CrossrefGoogle Scholar

  • [69] Bidel S., Silventoinen K., Hu G., Lee D.H., Kaprio J., Tuomilehto J., Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes, Eur. J. Clin. Nutr., 2007, doi:10.1038/sj.ejcn.1602712, 1–8 CrossrefGoogle Scholar

  • [70] Lee D.H., Jacobs D.R. Jr., Gross M., Kiefe C.I., Roseman J., Lewis C.E., et al., Gammaglutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study, Clin. Chem., 2003, 49, 1358–1366 http://dx.doi.org/10.1373/49.8.1358CrossrefGoogle Scholar

  • [71] Bidel S., Hu G., Qiao Q., Jousilahti P., Antikainen R., Tuomilehto J., Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes, Diabetologia, 2006, 49, 2618–2626 http://dx.doi.org/10.1007/s00125-006-0435-9CrossrefGoogle Scholar

About the article

Published Online: 2008-03-01

Published in Print: 2008-03-01


Citation Information: Open Medicine, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-007-0059-6.

Export Citation

© 2008 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Maria Ceymann, Eva Arrigoni, Hans Schärer, Anna Bozzi Nising, and Richard F. Hurrell
Journal of Food Composition and Analysis, 2012, Volume 26, Number 1-2, Page 128
[2]
Rakesh Jaiswal, Marius Febi Matei, Frank Ullrich, and Nikolai Kuhnert
Journal of Mass Spectrometry, 2011, Volume 46, Number 9, Page 933
[3]
Aneta Berner-Strzelczyk, Justyna Kołodziejska, Magdalena Piechota-Urbañska, Mariusz Piechota, and Marian Zgoda
Open Medicine, 2009, Volume 4, Number 1

Comments (0)

Please log in or register to comment.
Log in